Category: MDMA-Assisted Psychotherapy: MAPS-Sponsored Clinical Trials

Our upcoming randomized, double-blind, placebo-controlled Phase 2 study, located in Marin, California, will gather preliminary data about the safety and efficacy of MDMA-assisted psychotherapy for anxiety in 18 subjects diagnosed with a life-threatening illness.

Principal Investigator: Phil Wolfson, M.D.

Location: Marin, CA

The study protocol was approved by the Institutional Review Board (IRB) on September 16, 2014, by the U.S. Food and Drug Administration (FDA) on November 13, 2014, and by the Research Advisory Panel of California (RAP-C) on December 15, 2014. The U.S. Drug Enforcement Administration (DEA) approved the Principal Investigator's Schedule I license on March 13, 2015. This study is now enrolling.

For information about study participation, contact Dr. Phil Wolfson at This email address is being protected from spambots. You need JavaScript enabled to view it. .

Read Dr. Wolfson's published 1986 article on MDMA-assisted psychotherapy in the Journal of Psychopharmacology.

$608,000 estimated study cost • $187,000 raised • $421,000 still needed

Please consider donating today to help this study.